The DOI matches its Crossref record.
The purinergic receptor P2Y2receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation
Abstract
To cite this article:Müller T, Robaye B, Vieira RP, Ferrari D, Grimm M, Jakob T, Martin SF, Di Virgilio F, Boeynaems J‐M, Virchow JC, Idzko M. The purinergic receptor P2Y 2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation.Allergy 2010;65: 1545–1553. Background: Extracellular ATP contributes to the pathogenesis of asthma via signalling at purinergic receptors. However, the precise purinergic receptors subtypes mediating the pro‐asthmatic effects of ATP have not been identified, yet. Methods: In vivo studies were performed using the OVA‐alum model. Functional expression of the P2Y 2 purinergic receptor subtype on human monocyte‐derived dendritic cells and eosinophils was investigated using real‐time PCR, migration assays, and production of reactive oxygen species. Results: Compared to wild‐type animals P2Y 2−/− mice showed reduced allergic airway inflammation which can be explained by defective migration of blood myeloid DCs towards ATP in vitro and in vivo, whereas the influence of ATP on maturation and cytokine production was not changed. Additionally, ATP failed to induce migration of bone marrow–derived eosinophils from P2Y 2 R‐deficient animals. The relevance of our findings for humans was confirmed in functional studies with human monocyte‐derived DCs and eosinophils. Interestingly, stimulation of human DCs derived from allergic individuals with house dust mite allergen induced functional up‐regulation of the P2Y 2 R subtype. Furthermore, eosinophils isolated from asthmatic individuals expressed higher levels of P2Y 2 R compared to healthy controls. This was of functional relevance as these eosinophils were more sensitive to ATP‐induced migration and production of reactive oxygen metabolites. Conclusions: In summary, P2Y 2 R appears to be involved in asthmatic airway inflammation by mediating ATP‐triggered migration of mDCs and eosinophils, as well as reactive oxygen species production. Together our data suggest that targeting P2Y 2 R might be a therapeutic option for the treatment of asthma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
The airway epithelium in asthma
Lambrecht, B. N., & Hammad, H. (2012) · Nature Medicine · doi:10.1038/nm.2737 · Cited by 921
Dendritic Cells and Cancer Immunity
Gardner, A., & Ruffell, B. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.09.006 · Cited by 907
Nucleotide signalling during inflammation
Idzko, M., Ferrari, D., & Eltzschig, H. K. (2014) · Nature · doi:10.1038/nature13085 · Cited by 902
Self-citationLiving on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology
Morioka, S., Maueröder, C., & Ravichandran, K. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.04.018 · Cited by 391
Metadata
- Authors
- Müller, T., Robaye, B., Vieira, R. P., Ferrari, D., Grimm, M., Jakob, T., Martin, S. F., Di Virgilio, F., Boeynaems, J. ‐., Virchow, J. C., & Idzko, M.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2010-09-29
- Volume
- 65
- Issue
- 12
- Pages
- 1545-1553
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1482852619
- Cited by
- 161
- References
- 0
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The purinergic receptor P2Y2receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. https://app.cochat.ai/papers/10.1111/j.1398-9995.2010.02426.x
- The paper
- Müller, T., Robaye, B., Vieira, R. P., Ferrari, D., Grimm, M., Jakob, T., Martin, S. F., Di Virgilio, F., Boeynaems, J. ‐., Virchow, J. C., & Idzko, M. (2010). The purinergic receptor P2Y2receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation. Allergy. https://doi.org/10.1111/j.1398-9995.2010.02426.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.